FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 132 filers reported holding FLEXION THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,487,000 | +4.1% | 119,121 | -5.6% | 0.00% | -50.0% |
| Q4 2018 | $1,429,000 | -72.8% | 126,240 | -55.1% | 0.00% | -60.0% |
| Q3 2018 | $5,257,000 | -30.2% | 280,972 | -3.5% | 0.01% | -28.6% |
| Q2 2018 | $7,527,000 | +8.7% | 291,181 | -5.7% | 0.01% | 0.0% |
| Q1 2018 | $6,922,000 | -12.4% | 308,895 | -2.1% | 0.01% | +16.7% |
| Q4 2017 | $7,904,000 | +141.3% | 315,647 | +133.0% | 0.01% | +100.0% |
| Q3 2017 | $3,276,000 | +4.6% | 135,464 | -12.5% | 0.00% | 0.0% |
| Q2 2017 | $3,132,000 | -22.8% | 154,877 | +2.7% | 0.00% | -25.0% |
| Q1 2017 | $4,059,000 | +31.2% | 150,831 | -7.3% | 0.00% | +33.3% |
| Q4 2016 | $3,094,000 | -39.8% | 162,687 | -38.2% | 0.00% | -40.0% |
| Q3 2016 | $5,142,000 | +33.7% | 263,161 | +2.4% | 0.01% | +25.0% |
| Q2 2016 | $3,847,000 | +180.6% | 257,092 | +72.5% | 0.00% | +100.0% |
| Q1 2016 | $1,371,000 | -54.0% | 149,018 | -3.7% | 0.00% | -33.3% |
| Q4 2015 | $2,983,000 | +193.6% | 154,786 | +126.4% | 0.00% | +200.0% |
| Q3 2015 | $1,016,000 | – | 68,376 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,500,000 | $36,270,000 | 4.72% |
| Gagnon Advisors, LLC | 108,498 | $2,623,000 | 1.99% |
| NEXTHERA CAPITAL LP | 271,136 | $6,556,000 | 1.69% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 883,321 | $21,359,000 | 1.39% |
| GILDER GAGNON HOWE & CO LLC | 3,961,647 | $95,793,000 | 1.35% |
| GAGNON SECURITIES LLC | 144,331 | $3,490,000 | 1.30% |
| MILLER VALUE PARTNERS, LLC | 1,181,325 | $28,564,000 | 1.23% |
| SCHOLTZ & COMPANY, LLC | 55,250 | $1,336,000 | 1.05% |
| ARDSLEY ADVISORY PARTNERS LP | 175,000 | $4,232,000 | 0.56% |
| Ratan Capital Management LP | 32,077 | $776,000 | 0.47% |